Telithromycin is as effective as comparator antibacterials in the treatment of lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 561s Year: 2002
Evaluation of antibiotics therapy for low respiratory tract infections Source: Eur Respir J 2007; 30: Suppl. 51, 406s Year: 2007
Pharmacokinetics and pharmacodynamics of newer fluoroquinolones in patients with lower respiratory tract infections Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012
Efficacy and safety of Cefdinir in lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 420s Year: 2002
Immunomodulatory effects of moxifloxacin in human respiratory tract infection Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Antibiotic switch therapy in lower respiratory tract infections Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009
Telithromycin is highly efficacious in the treatment of lower respiratory tract infections Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003
Fluoroquinolones and lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=94 Year: 2004
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection in which Streptococcus pyogenes was isolated in sputum culture Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009
Bacterial agents of community-acquired lower respiratory tract infections: observational study on antimicrobial drugs susceptibility Source: Eur Respir J 2002; 20: Suppl. 38, 421s Year: 2002
Lower respiratory tract infections: bacteria and virus, antibiotics and steroids Source: Annual Congress 2008 - Infection year in review Year: 2008
Influence of antibiotic resistance of pseudomonas aeruginosa on presenting features of community-acquired lower respiratory tract infections Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011
Pharmacological interactions between antibiotics and other drugs in the treatment of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=229 Year: 2004
Efficacy and safety of azithromycin vs. clarithromycin for the treatment of community-acquired pneumonia due to legionella pneumophila Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004
High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult patients with respiratory tract infections Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Macrolides and lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=78 Year: 2004
Long term treatment with azithromycin in chronic respiratory infections with pseudomonas aeruginosa Source: Eur Respir J 2006; 28: Suppl. 50, 558s Year: 2006
Population pharmacokinetics and pharmacodynamics analysis of vancomycin in patients with severe lower respiratory tract gram-positive infections Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Streptococcal resistance to antibiotics in children with upper respiratory tract infections. Epidemiological aspects Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology Year: 2010